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Abstract
Cationic lipids are considered to be capable of efficiently and safely mediating DNA transfer into cells, although
expression is transient. A new family of cationic lipids, called phosphonolipids, has been developed, with the relationship
between the hydrophobic domain of the lipid molecules and the significant enhancement of transduction efficiency in a
non-adherent cell line characterised in the present study. The kinetics of transfection efficiency were also investigated. Our
results demonstrate that the peak of the transient expression of these reporter genes mediated by cationic lipids occurred
within 3 to 14 days, depending on the aliphatic chain length of the complex used and on its formulation in the presence or
absence of DOPE. Furthermore, the kinetics of transgene expression were found to differ in adherent and non-adherent
cells. These results were obtained using three different techniques: CPRG, luminescence, and FACS-gal, and were in
agreement with electron microscopy studies. We thus hypothesized that the plasma membrane composition of cells could
affect the efficiency of transfection with cationic lipids. Our results suggest that phosphonolipids constitute a promising
class of compounds for gene transfer protocols, and that galenic optimization should improve and modify the transfection
efficiency of these DNA–lipid complexes. q 1998 Elsevier Science B.V.
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1. Introduction
Over the past decade cationic lipids have been
extensively used to deliver genes to a variety of
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w xdifferent cell lines and tissues 1–7 and have shown
promise for in vivo gene transfer as well as in gene
w xtherapy clinical trials 8–16 . Although a large num-
wber of cationic lipids have been developed 1,5,17–
x24 , their mechanism of gene delivery and the rela-
tionship between the structure and function of these
compounds is yet to be fully elucidated.
In general, cationic lipids are composed of three
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main structural features: a cationic polynucleotide
binding domain, a hydrophobic domain and a nega-
tively charged counter-ion. The transfection mecha-
nism of the DNA–lipid complex across the cell
plasma membrane is not yet fully understood, but it
has been shown that only a small proportion of the
complex is conveyed to the nucleus producing a
short-term and transient expression that usually de-
clines within a few days. To the present time, the
kinetics of transgene expression have not been well
studied or documented. They are, however, a critical
parameter for the development of optimal vectors to
transfect a target cell or tissue with a gene of interest.
w xIn a previous study 25 , we reported on the trans-
 .fection of a reporter gene bgal using a new family
of vectors called cationic phosphonolipids. A series
w xof 24 new molecules were synthesized 26 , with 7 of
them displaying a high transfer efficiency in hemato-
poietic cell lines. The present work deals with inves-
tigations carried out on the kinetics of transgene
expression in non-adherent cells transfected with a
w xphosphonolipid–DNA complex or lipoplex 27 . To
assess b-galactosidase activity we carried out three
different assays for a 32-day period following trans-
fection; these being a Chlorophenol Red b-D-galacto-
pyranoside or CPRG assay, a luminescence assay,
and flow cytometry. It is currently accepted that most
cationic lipids must be formulated with a neutral
phospholipid e.g., di-oleylphosphatidylethanolamine
 ..DOPE in order to provide optimal transfection
w xactivity 28,29 . In fact, DOPE stabilizes most types
of cationic lipids in a lipid bilayer and enables the
penetration of cationic lipids into the cell by increas-
w xing membrane fusion 28 . The neutral phospholipid
requirement for transfection activity and its influence
on the kinetics of transgene expression were also
investigated in the present study.
We show here that the length of the lipid aliphatic
side-chain plays a critical role in the transfection
efficiency and we determine the kinetic rate of trans-
gene expression. Moreover, we demonstrate a peak in
expression with C14 aliphatic side-chain compounds
three days after transfection. In contrast, expression
with C18 compounds was maximum at day 14.
Finally, we show that the addition of DOPE to the
formulation of these compounds drastically shifted
the activity of the C14 complexes and resulted in
peak expression 14 days after transfection.
2. Materials and methods
2.1. Cell-culture
2.1.1. K562 cells
The human hematopoietic non adherent cell line
K562 was obtained from American Type Culture
 .Collection no. ccl 243 ATCC, Rockville, MD, USA
and was maintained in RPMI-1640 medium Gibco-
.BRL, Cergy Pontoise, France supplemented with
 .10% fetal calf serum FCS , 0.2 mM glutamine, 100
Urml of penicillin, 100 U of streptomycin and 1%
fungizone. Cells concentrations were maintained be-
tween 105rml and 106rml.
2.2. Plasmid
The plasmid used was pCMVLacZ, containing the
LacZ gene encoding b-galactosidase under the con-
 .trol of the cytomegalovirus CMV promoter. It was
 .grown in Epicurian coli Stratagene , extracted and
 .purified on QUIAGEN-500 columns Coger . The
structure and purity were checked after enzymatic
digestion with EcoRI by electrophoresis in a 0.7%
agarose gel followed by ethidium bromide staining to
detect DNA. DNA concentration was determined by
absorbance at 260 nm.
2.3. Cationic liposomes
A series of seven cationic phosphonolipids synthe-
sized by our group was studied in this report. These
original molecules were obtained by the Mannich
reaction from fatty phosphites followed by quaternar-
w xization of the resulting aminophosphonates 26 . Their
structures are presented in Fig. 1 and Table 1. Each
of the cationic phosphonolipids was prepared alone
Fig. 1. Structure of cationic phosphonolipid molecules.
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Table 1
Formula of the cationic phosphonolipids used
R R1 X Phosphonolipids
yC12:0 CH l GLB 4163
yC14:0 CH l GLB 733
yC14:0 CH Cl GLB 843
yC16:0 CH l GLB 2393
yC18:0 CH l GLB 2123
yC18:1 CH l GLB 433
yC18:1 CH Cl GLB 583
or in combination with the neutral lipid DOPE Sigma,
.Saint Quentin Fallavier, France . The phosphono-
lipids were formulated by mixing chloroform solu-
tions of the different lipids in glass vials, then chloro-
form was removed by rotary evaporation to produce
dried lipids films. A total of 1 ml of sterile pyrogen-
free DI water was added per mg of lipid and the vials
were sealed and stored one night at q48C. Small
 .unilamellar vesicles suv were prepared by sonicat-
ing the compounds for 10 min in a sonicator Pro-
. w xlabo, Paris, France 30 .
2.4. Transfection protocol
K562 non adherent cells were seeded 1 h before
transfection onto a 24-well plate at 100,000 cells per
well in 250 ml of RPMI medium. The cationic
phosphonolipid–DNA complexes were prepared by
adding the appropriate amounts of RPMI serum
.  .free , pCMVbgal DNA 1 to 8 mg and the liposome
 .formulation 12.5 ml into a 5-ml polystyrene tube to
get a total volume of 200 ml. Then, the tube was
incubated 30 min at room temperature. A total of 200
ml of the resultant transfection complex were added
to each well, and the cells were incubated for 2.5 h at
378C. Then, 1 ml of the appropriate growth medium
supplemented with 10% of calf foetal serum per well
was added and the cells were cultured until carrying
out b-galactosidase activity detection assays every 3
.or 4 days during one month . In long term-cultures,
the medium was changed every 3 or 4 days and the
cells were passaged every week. At the end of the
transfection period, the cells were removed, cen-
trifuged and washed twice with PBS. The cell pellet
obtained was divided into three parts: the first one
was used for the CPRG analysis, the second one for
the chemiluminescent b-galactosidase assay, and the
last one for the flow cytometric FACS-gal assay. All
the experiments were carried out 4 times.
( )2.5. CPRG Chlorophenol red galactopyranoside test
The cells were assayed for expression of b-
galactosidase using the CPRG Chlorophenol red
.galactopyranoside spectrophotometric test as de-
w xscribed previously 29 . Succinctly, the cells were
lysed by adding 50 ml of lysis buffer K HPO 0.12 4
.M, triton 0.2% per well. Fifty microliters of the cell
extract were transferred to microtiter plate and 50 ml
of phosphate buffered-saline containing 0.5% bovine
serum albumin was added to each well. The b-
galactosidase activity present in each well of the
transfection plate was converted into an absolute
level of b-galactosidase protein per well from the
b-galactosidase standard curve. This standard curve
was prepared by serially diluting 2-fold a b-galacto-
 . sidase standard obtained from Sigma in PBS phos-
. phate-buffered saline containing 0.5% BSA bovine
.serum albumin to give 250, 125, 62.5, 31.25, 15.62,
7.81, 39, 1.95 ng of b-galactosidase per well. A total
of 150 ml of substrate, 1 mgrml of ChloroPhenol red
galactopyranoside in b-galactosidase buffer 60 mM
sodium dibasic phosphate buffer, pH 8, 1 mM mag-
nesium sulfate, 10 mM KCl, 50 mM b-mercapto-
.ethanol were added to each well, and the plate was
read at 580 nm in a microtiter plate reader allowing
the color to develop 10 min to 24 h depending on
.the level of expression obtained .
2.6. Luminescent detection of b-galactosidase
b-Galactosidase activity was measured with a lu-
m inescent b -galactosidase detection kit
 .Clontech .The cells were lysed in 50 ml of lysis
 .buffer Clontech , 25 ml of the supernatant were
 .mixed to 50 ml of reaction buffer Clontech in a
microtiter plate. The plate was incubated at room
temperature for 90 min. b-Galactosidase activity in
the supernatant was quantified with a luminometer
 .LMR Dynex to integrate light emission over a 5-s
reaction period. b-Galactosidase activity present in
each well of the microtiter plate was converted into
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an absolute level of b-galactosidase protein per well
from the b-galactosidase standard curve.
2.7. Analysis of b gal expression in ˝iable cells using
a FACS-gal assay
To investigate gene expression in the cells, a
w xFACS-gal assay 31 was also used. According to this
flow cytometry method, enzyme activity is measured
by using a fluorogenic substrate fluorescein di-b-D-
.  .galactopyranoside FDG hydrolyzed by b-galacto-
sidase inside cells. For this assay 1.105 cells in a
35-mm tissue culture plate were transfected with an
optimal phosphonolipid-to-DNA ratio. The FACS-gal
assays were done basically as described elsewhere
w x32 . Briefly, aliquots of cells were suspended in 50
ml of growth medium and warmed at 378C. FDG 2
.  .mM in 98% distilled water Sigma was warmed at
378C and 50 ml were added to each 50 ml aliquot of
cells. The cells and FDG were rapidly mixed and
immediately incubated in a 378C bath for 1 min. The
cells were removed from the water bath, 1 ml or
more of ice cold growth medium or phosphate-
 .buffered saline PBS was added to the cells and
incubated on ice until analyzed on a FACScan Be-
.cton–Dickinson . With this fluorescent assay, the
 .percentage of positive cells LacZq was evaluated
by comparison with a control transfected with the
same quantity of lipid–DNA complex in this control
.the DNA used was pBR322 .
2.8. Electron microscopy
Cells were fixed with 1.25% phosphate buffered
glutaraldehyde solution for 30 min at room tempera-
 .ture and centrifuged 2000 rpm, 10 min . After wash-
ing with the same buffer, cells were post-fixed in 1%
osmium tetraoxyde for 30 min, then washed with 0.1
M phosphate buffer. Cells were kept at 48C during
night in 70% ethanol. They were dehydrated in
ethanol 95% for 2=15 min and in 100% ethanol for
3=20 min. Cells were embedded in Epon-Araldite
Resin Epox 812 ml, Araldite 506 3 ml, DDSA 5 ml,
.NMA 4.5 ml and DMP 30 1.5% Ultrathin sections
 .50 nm were cut with a diamond knife and stained
 .with an ultrastainer Leica . They were examined
with a Jeol JEM 100S microscope.
3. Results
3.1. Cationic lipids
With the aim of mimicking the phosphate linkage
of natural phospholipids, a series of new cationic
phosphonolipids was designed. The novel family of
Fig. 2. Comparison of 7 cationic phosphonolipids efficiency in the K562-cell population transfection performed with pCMV bgal plasmid
  .  .  .DNA GLB43 RsC18:1, R1sCH , Xs I , GLB58 RsC18:1, R1sCH , XsCI , GLB73 RsC14:0, R1sCH , Xs I , GLB843 3 3
 .  .  . RsC14:0, R1sCH , XsCI , GLB212 RsC18:0, R1sCH , Xs I , GLB239 RsC16:0, R1sCH , Xs I , GLB416 RsC12:0,3 3 3
..  .R1sCH , Xs I . Three days after transfection, the cells were assayed for b-galactosidase activity with CPRG B and luminescent3
 .I tests. Each point indicates the mean value of the b-galactosidase quantity derived from 4 transfections and the standard deviation
from this mean.
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Fig. 3. Flow cytometry analysis of the positive cell percentage in a K562-cell population transfected with pCMV bgal plasmid DNA.
 .  .  .  .Cells were assayed 3 days after lipofection. A Obtained with C14:0 compound GLB 73 and B with C18:1 compound GLB 43 .
 .Grey curve: negative control K562 cells transfected with a pBR 322 plasmid DNA .
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cationic lipids used was synthesized as previously
w xdescribed 26 . In order to understand the relationship
between structure and activity on the one hand, and
between structure and kinetics of reporter gene ex-
pression on the other, 7 phosphonolipids containing
 .C12 to C18 acyl chains were synthesized Table 1 .
Different formulations that included the neutral phos-
pholipid DOPE were prepared so as to evaluate the
role of DOPE in both the transfection activity of
these molecules and in the kinetics of transgene
expression.
3.2. Influence of aliphatic chain length on transfec-
( )tion efficiency at day 3
To assess the relationship between phosphonolipid
hydrophobic domain structure and transfection activ-
ity, a panel of phosphonolipids differing only in the
composition of the aliphatic side-chain was studied,
 .  .i.e., GLB43 C18:1 , GLB58 C18:1 , GLB73
 .  .  .C14:0 , GLB84 C14:0 , GLB212 C18:0 , GLB239
 .  .C16:0 , GLB416 C12:0 . The counter-ion used was
Cly in GLB84 and GLB58, and Iy in all other
compounds.
In order to compare transfection activities, K562
cells were assayed for b-galactosidase expression 72
h after transfection using the three different assays
outlined in Section 2. The results obtained at day 3
after transfection using the CPRG test and the lumi-
nescence assay are presented in Fig. 2. Irrespective of
 .the assay employed, di-myristil C14 had the most
efficient level of transfection, followed by di-oleyl
 .C18:1 ; with the three least efficient transfecting
 .compounds being di-palmityl C16:0 , di-steryl
 .  .C18:0 and di-lauryl C12:0 , all of which had simi-
lar levels of efficiency. The decline in the transfec-
tion activity of C12:0 was correlated with a visible
reduction in the number of cells per well resulting
from a possible toxicity of the cationic lipid molecule.
This was confirmed by the cytotoxicity assay data
.not shown .
A comparison of the saturated compound di C18:0,
with di C18:1 highlighted the beneficial effect of
additional unsaturation. As previously reported, two
phosphonolipid analogues with an iodide anion
 .GLB43, GLB73 resulted in higher transfection effi-
ciencies than the same compounds with a chloride
 .anion GLB58, GLB84 . It should be noted that the
transfection activities measured with the lumines-
cence assay were higher than those obtained with the
less sensitive CPRG test, although the two sets of
data were in good agreement. The transfection activi-
ties of these different compounds were also compared
 .using a FACS-gal assay Fig. 3 . In this assay, the
 .intensity of the fl1 green fluorescence was propor-
tional to b-galactosidase expression. The fl1 fluores-
cence intensities measured 72 h after the transfection
 .  .of K562 cells with GLB73 C14:0 or GLB43 C18:1
are displayed in Fig. 3a and b, respectively. Fig. 3a
shows that 80% of the K562 cells were efficiently
transfected with GLB73, whereas only 15% of the
K562 cells could be transfected with GLB43 Fig.
.3b . The fl1 intensity was compared to the intensity
measured in control cells transfected with the same
Fig. 4. Influence of aliphatic chain length on the transgene kinetic expression, transfections of the K562 cells were performed with
various cationic phosphonolipids and pCMV bgal plasmid DNA. The cells were assayed for b-galactosidase activity within 3 and 32 days
after transfection. Each data point indicates the mean value of the b-galactosidase quantity derived from four transfections and the
standard deviation from this mean.
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 .  .  .Fig. 5. Flow cytometry analysis of the transgene kinetic expression, after transfection using a C14:0 GLB73 A or a C18:1 GLB43
 .B . K562 cells were transfected using a pCMV bgal plasmid DNA and assayed for b-galactosidase activity 3, 7 and 14 days after
 .lipofection. Grey curve: negative control K562 cells transfected with a pBR 322 plasmid DNA .
( )V. Floch et al.rBiochimica et Biophysica Acta 1371 1998 53–7060
quantity of lipid–DNA complex with pBR322 as
DNA. The results obtained with the FACS-gal assay
were in agreement with those of the two other tests,
 .with transfection using GLB73 C14:0 greater than
 .that obtained with GLB43 C18:1 .
3.3. Influence of aliphatic chain length on transgene
expression kinetic
In most experiments described in the literature,
transfected cells are usually assayed for reporter gene
expression 24 to 48 h after transfection. In the present
work, K562 cells were transfected with the 4 most
  y.efficient phosphonolipids GLB43 C18:1, I ,
 y.  y.GLB58 C18:1, Cl , GLB73 C14:0, I , GLB84
 y.C14:0, Cl , and assayed for b-galactosidase ex-
pression on different days 3, 5, 7, 10, 14, 17, 21, 24,
.28, 32 days . The same experiment was carried out
with GLB212, GLB239, GLB416, however the yield
of b-galactosidase was very low, at less than 10 ng
 .data not shown .
Results describing the kinetics of the luminescence
assay are presented in Fig. 4. They highlight the fact
that the aliphatic chain length of the phosphonolipid
used for the transfection alters transgene expression
kinetics. Maximal transgene expression was observed
between days 3 and 5 after transfection for the C14:0
 .compounds GLB73, GLB84 . b-Galactosidase lev-
els began to decline on day 6 and were undetectable
after 14 days. The two C14:0 compounds exhibited
similar patterns of activity. For the C18:1 compounds
 .GLB43, GLB58 , maximal transgene expression was
only observed at day 14. When the cells were trans-
fected using GLB43 it was possible to detect b-
galactosidase activity up to day 28. The profiles
obtained with the two C18:1 compounds were simi-
lar, although GLB58 provided a lower yield than
GLB43. It was therefore concluded that, irrespective
 .of the aliphatic chain length C18 or C14 , the
 y y.counter-ion used I or Cl did not influence the
kinetic expression of the transgene.
Similar results were obtained with the FACS-gal
assay and the b-galactosidase activity detection test
 .Fig. 5 . The fl1 fluorescence was maximum 3 days
 .after transfection using GLB73 Fig. 5a , whereas
with GLB43 the maximum occurred after 14 days
 .Fig. 5b .
3.4. Relationship between phosphonolipids formula-
( )tion and transfection efficiency at day 3
Most currently produced cationic lipid reagents
contain a mixture of a cationic lipid and a neutral
phospholipid i.e., dioleylphosphatidylethanolamine
 ..DOPE . The transfection activity of the 7 cationic
phosphonolipids formulated in the presence or ab-
 .sence of DOPE in 2 ratios; 1:1, 2:1 was compared
72 h after transfection using the luminescent b-
galactosidase detection test. The results obtained are
Fig. 6. Comparison of 6 different DOPE-containing cationic phosphonolipids reagents in transfection assay carried out on a K562-cell
population with pCMV bgal plasmid DNA. Three days after transfection, b-galactosidase activity was determined with a luminescent
assay. Each data point indicates the mean value of the b-galactosidase quantity derived from four transfections and the standard deviation
from this mean.
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Fig. 7. Flow cytometry analysis of the positive cell percentage in a K562-cell population transfected with pCMV bgal plasmid DNA. The
 .cells were assayed 3 days after lipofection. Curves obtained with C14:0 compound GLB73 formulated without DOPE A and with DOPE
 .  .  .1:1 B . Grey curve: negative control K562 cells transfected with a pBR 322 plasmid DNA .
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Fig. 8. Influence of DOPE on transgene kinetic expression after transfection. K562 cells were transfected with a pCMV bgal plasmid
 .DNA and assayed for b-galactosidase activity within 3 and 32 days after lipofection with a luminescent assay. A was obtained with
 .C14:0 compound, GLB 73, B with GLB 84. Both were formulated with and without DOPE. Each data point indicates the mean value of
the b-galactosidase quantity derived from four transfections and the standard deviation from this mean.
Fig. 9. Influence of DOPE on transgene kinetic expression after transfection of a K562-cell population with a pCMV bgal plasmid DNA.
 .b-galactosidase activity was assayed within 3 and 32 days after lipofection with a luminescent assay. A Obtained with C18:1 compound
 .GLB 43 and B with GLB 58. Both were formulated with and without DOPE. Each data point indicates the mean value of the
b-galactosidase quantity derived from four transfections and the standard deviation from this mean.
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summarized in Fig. 6. All of the C14:0 cationic
phosphonolipids formulated with DOPE decreased
transfection activity to similar levels displayed by
that of the C18:1 compounds.
w xIt has been previously reported 29 that a 2-5-fold
activation in the adherent COS 7 cell line was ob-
tained with cationic vesicles formulated with 50%
DOPE; however no such result was observed in the
 .Fig. 10. Electronic photomicrographs of lipoplexes. A Lipoplex A formulated with DNA C18:1 compound and DOPE, concentric
 .regular lamellar pattern, B Lipoplex B formulated with C14:0 compound, fingerprint-like pattern. Bar indicates 0.1 mm.
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present study. The C12:0, C16:0 and the C18:0
cationic phosphonolipids formulated with DOPE were
always less active than the C14:0 and the C18:1
analogues formulated in the presence or absence of
DOPE. Therefore, regardless of the phophonolipid–
DOPE ratio used, the transfection activity at day 3
was always higher when DOPE was not added to the
formulation.
Fig. 11. Lipoplex B 2.5 h after transfection start: low magnification showing the lipoplex penetration. Bar indicates 1 mm. 11A: Detail:
Lipoplex B begins to penetrate in a fold of the cell membrane. Bar indicates 0.2 mm. 11B: Detail: Lipoplex B in the cytoplasm of K562
cell inside a vacuole. Bar indicates 0.2 mm.
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FACS-gal assay results 72 h after transfection of
K562 cells with GLB73 formulated in the presence or
absence of DOPE are presented in Fig. 7a and b. The
addition of DOPE to the GLB73 formulation induced
a decrease in the fl1 fluorescence intensity, with 80%
of cells efficiently transfected using GLB73 com-
pared to only 7% when the formulation contained
DOPE.
 .  .  .Fig. 12. A Lipoplex A C18:1 DOPE DNA 2.5 h after transfection starts, the lipoplex is outside the cell. Bar indicates 5 mm. B
Lipoplex inside the cell, 4 days after transfection starts. Bar indicates 2 mm—insert: lipoplex at high magnification. Bar indicates 0.4
mm.
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3.5. Influence of DOPE on transgene kinetic expres-
sion
3.5.1. C14:0 compounds
K562 cells were transfected with C14:0 phospho-
nolipids formulated in the presence or absence of
DOPE. After transfection, the cells were assayed for
b-galactosidase expression for up to 32 days. Two
 .phosphonolipid–DOPE ratios were used 1:1 and 2:1 ,
with the luminescence assay results for these experi-
ments presented in Fig. 8a and b. When GLB73 was
used without DOPE, b-galactosidase activity was
 .maximum at day 3 Fig. 8a . In the presence of
DOPE in the cationic lipid formulation the maximum
activity was delayed to day 14, irrespective of the
ratio of DOPE used. Although the profile of the
kinetic expression of the transgene was the same after
 .transfection with GLB73 DOPE 1:1 and GLB73
 .DOPE 2:1 , the prior had a higher transfection effi-
ciency than the latter. In this experiment, a higher
b-galactosidase activity after transfection with GLB73
in the absence of DOPE was observed at day 3.
 .Similar results were observed with GLB84 Fig. 8b ,
demonstrating once more that the counter-ion does
not affect the kinetics of transgene expression.
3.5.2. C18:1 compounds
Similar experiments were carried out with the
 .C18:1 phosphonolipids Fig. 9a and b . Irrespective
of the C18:1 compound and the formulation used
 .with or without DOPE , b-galactosidase activity was
always maximum at day 14 after transfection. Fig. 9a
and b show that the most appropriate phosphono-
lipid–DOPE ratio for optimal transfection activity
was 2:1, regardless of the C18:1 phosphonolipid used.
Moreover, the two C18:1 profiles were similar, al-
though the b-galactosidase activity with GLB58 was
lower than that with GLB43 in both the presence and
absence of DOPE.
No influence of the counter-ion on the kinetics of
transgene expression was observed and all results
were confirmed with the CPRG test and FACS-gal
assay.
 .  .Fig. 13. Lipoplex A 17 days after transfection: lipoplex is observed outside the cell long arrow and inside the cell short arrow . Bar
 .indicates 5 mm. Insert: detail of lipoplex inside the cell short arrow at high magnification. Bar indicates 0.2 mm.
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3.6. Electron microscopy study
Electron microscopy enabled us to follow the fate
of the lipid–DNA complexes from 2.5 h to 17 days
post-transfection. In a first set of experiments, the
cells were transfected using two different lipoplexes,
2.5 h after the transfection the cells were fixed and
electron microscopy study was carried out. Two
lipid–DNA complexes were used, consisting of a
 .C18:1 compound with DOPE Lipid A and a C14:0
 .compound Lipid B . The two lipoplexes provided
very different results concerning the shape. The first,
DNA–lipid A, developed a highly ordered pattern as
illustrated in Fig. 10a with regular concentric lamel-
lae and a ‘myeline figure’ aspect. It possibly repre-
sents a strand of DNA surrounded by several bilayers
 .of lipids. Lipoplex B Fig. 10b showed a bilayer
structure but with a quite different fingerprint-like
pattern with aggregated and fused particles. We no-
ticed that 2.5 h after transfection, microscopy images
showed that lipoplex B had bound to the plasma
membrane and was incorporated into the cell by
 .endocytosis or phagocytosis . The mechanism is
demonstrated in Fig. 11, highlighting the different
steps that the process involves. Invaginations closely
follow the particle boundaries. Fig. 12a shows that
2.5 h after transfection with lipoplex A C18:1
.DOPE , the lipoplex was still outside the cell, it
could be observed within the cytoplasm only after 4
 .days following transfection Fig. 12b . When the
K562 cells were transfected with a C18:1 compound
in the presence of DOPE, lipoplex structures were
present inside and outside the cells for up to 17 days
 .post-transfection Fig. 13 .
4. Discussion
The objective of this work was to examine the
 .influence of i hydrophobic domain chemical struc-
 .  .ture and ii formulation with or without DOPE of
cationic phosphonolipids on the kinetic expression of
a transgene in a non-adherent hematopoietic cell line.
The cationic phosphonolipids studied consisted of
compounds with C18:1 to C12:0 symmetric hydro-
carbon side-chains. All compounds were formulated
in both the presence and absence of DOPE 1:1,
.w:w . The major findings of the study highlighted
that:
-Cationic phosphonolipids can transfect the
hematopoietic non-adherent cell line K562, with
transgene expression being detected up to 28 days
after transfection.
-Formulation of the phosphonolipids in the pres-
ence of DOPE did not enhance the transfection
efficiency of cationic phosphonolipids in the non-
adherent K562 cell line.
-The formulation and chemical structure of cationic
phosphonolipids influence the kinetic expression of
the transgene.
Many authors have stressed the fact that non-ad-
herent cells are difficult to transfect with cationic
w xvectors 33,34 . We report here a transfection effi-
ciency with the K562 cell line equivalent to that
observed with other adherent cell lines such as CFT1
w xand COS 7 35 using cationic phosphonolipids. Opti-
mal results were obtained for all cell lines with a
 .C14:0 compound i.e., GLB73 . However, it was
necessary to include DOPE in the formulation to
obtain efficient transfection in the CFT1 and COS 7
adherent cell lines. In most publications, the lipid
formulations tested have been prepared with DOPE,
and the cells assayed for gene reporter activity 24 or
48 h after transfection. In the present study, under
 .these transfection conditions i.e., with DOPE an
efficient transfection of a lipid–DNA complex into
non-adherent K562 cells was not obtained. Optimum
results were obtained 72 h after the transfection of a
C14:0 compound not formulated with DOPE. The
most efficient transfection using a lipid formulation
prepared with DOPE was observed 7 or 14 days after
transfection. With a C18:1-DOPE compound, trans-
gene expression was observed for up to 28 days. It
could be of interest to know if the conclusion that the
apparently poor transfection of non adherent cells by
cationic lipids is a consequence of failure to look for
transfection at long times is also valid for other types
of cationic lipids. Under optimized conditions for
transfection, our results were not consistent with a
marked decrease in transfection efficiency between
adherent and non-adherent cells described by some
w xauthors 33,34 . These observations led us to assume
that cationic phosphonolipids do not induce differ-
ences in transfection efficiency between adherent and
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non-adherent cell lines. On the other hand, they
modify the kinetic expression of the transgene.
 w x.Several authors see e.g., Refs. 28,29 have re-
ported that the inclusion of DOPE in the cationic
lipid formulation increases transfection activity by
enhancing mixing and fusion of liposomes and cell
membranes. DOPE forms inverted hexagonal phase
w xstructures at ambient temperature 36,37 , and may
therefore facilitate the formation of similar structures
when formulated with cytofectins. In this study, we
compared the transfection efficiency of different
cationic phosphonolipids formulated in the presence
or absence of DOPE. Irrespective of the aliphatic
chain length, the inclusion of DOPE in the cationic
phosphonolipid formulation resulted in a decrease in
transfection efficiency when the cells were assayed
for b-galactosidase activity 3 days after transfection.
DOPE is not always required to obtain transfection
efficiency as has been illustrated by the high activity
w xfrequently observed with the DOTAP reagent 38 .
The EM images obtained with a C14:0-DNA com-
plex were similar to those described by Labat-Moleur
w xet al. 34 who used Transfectam. The complexes
appeared as aggregated and fused liposomes together
with tubular spaghetti-like structures which may be
considered as characteristic dark fingerprints. Stern-
w xberg et al. 39 reported improved transfection activ-
ity of the spaghetti-like structures. When DOPE and
 .the C18:1 compound i.e., GLB43 were used to
prepare the lipoplex, the EM appearance was similar
w xto that reported by Zabner et al. 40 who used
DMRIErDOPE and observed coiled bilayer-like
structures with a myeline figure aspect. Zhou and
w xHuang 41 also reported the same myeline figure
aspect. These very different morphological features
provided by the two types of lipoplex could explain
variations observed in transfection activity 3 days
after transfection.
Various reports have shown that chemical changes
in the three principal structural motifs of cytofectins
w xcan modify transfection efficiency 38,42,29 . Such
structureractivity studies have begun to establish
general principles which can be applied to obtain
optimum transfection efficiencies. While there has
been no previous report on the importance of the
chemical structure on the kinetic expression of trans-
genes, we have been able to establish one such
 .relation. Using a C14:0 compound i.e., GLB73 an
elevated expression was observed at an earlier stage
after transfection, but decreased rapidly such that no
expression could be detected after 7 days. Adding
DOPE to the C14:0 formulations i.e., GLB73,
.GLB84 delayed the peak transgene expression such
that it was observed only at day 14. Using C18:1
 .compounds i.e., GLB43, GLB58 in the presence or
absence of DOPE, maximal transgene expression was
observed 14 days after transfection.
According to the hypothesis originally advanced
w xby Akao et al. 43 stating that cytofectin transfection
activity and transfection lipid bilayer fluidity are
directly correlated, one of the primary requirements
of an amphiphile for DNA transfection would be that
the T phase transition temperature between the gelc
.and the crystalline phases is lower than 378C. Conse-
quently, the transfection lipid is assumed to be under
a fluid crystalline state at cell culture temperatures.
w xResearchers supporting this hypothesis 29,43 have
relied on the analysis of a limited number of cyto-
fectin analogues and cell lines. At cell culture tem-
perature, C14:0 compounds are supposed to be under
 .lamellar phase assumed T )378 , and C18:1 com-c
pounds under inverted hexagonal phase assumed
.T -378 . The hexagonal inverted phase structuresc
have been described as transfection enhancing struc-
w xtures 44 ; DOPE is known to form inverted hexago-
w xnal structures at ambient temperature 36,37 , such
that it may facilitate the formation of similar struc-
tures when formulated with cytofectins. We postu-
lated that the lipid composition of non-adherent cells
could interfere with the uptake mechanism of the
lipoplex. The same reasoning could be applied to the
release of the lipoplex from the endosome because in
our experiments DOPE did not enhance the release of
the lipoplex from the endosome. EM studies showed
lipoplex formulated with DOPE in endosomes for up
to 17 days following transfection.
The results described here are not due to a particu-
lar characteristic of the cationic phosphonolipid be-
 . w xcause with adherent cells CFT1, COS 7 35 we
confirmed all of the classical published hypotheses
dealing with the DOPE-enhancing transfection effect.
No differences were observed in the kinetics of trans-
gene expression after transfection with C14:0 or C18:1
compounds.
It is important to highlight that experiments con-
cerning adherent and non-adherent cells were per-
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formed under the same conditions. Non-adherent cells
have often been reported as being difficult to trans-
fect, and hypotheses explaining the low transfection
efficiency of cationic vectors on this cell type are
w xlimited. Labat-Moleur et al. 34 noted that lympho-
cytes and presumably other non-adherent cells are
difficult to transfect with cationic vectors because
DNA particles do not efficiently bind to the cell
surface. This suggests that the particles bound to
membrane components involved in Ca2q-mediated
cell anchoring to the extracellular matrix are present
on adherent cells only. Our EM studies were not
consistent with these observations: cationic phospho-
nolipid cell-binding and endocytosis images were
observed 2.5 h after transfection. Examples in the
literature comparing the lipid composition of erythro-
 . cyte non-adherent cells and liver cell adherent
.cells plasma membranes have shown variations in
w xphospholipid percentages 45,46 . PE compounds rep-
resent 7% of the liver cell lipid membrane and 18%
of the erythrocyte lipid membrane, and are known to
be under inverted hexagonal phase at ambient tem-
perature. The presence of DOPE or C18:1 com-
pounds entails the formation of a structure which
favours neither lipoplex penetration nor its release by
endosomes. Additional studies focussed on the com-
position of plasma membranes of adherent and non-
adherent cells would aid in the explanation of our
results. Moreover, one may assume that other ele-
ments in the cell environment might affect the trans-
fection process.
The results reported here are important, for they
demonstrate that the short term activity of phospho-
nolipids depends on their formulation, and can thus
be altered. Moreover, these findings highlight that
some specific molecules can be used to obtain maxi-
mum expression activity two weeks after transfection.
This could provide the basis for further research in
this field.
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